4th Nov 2025 07:00
![]() | |||||
Condensed Consolidated Interim Statement of Financial Position as at September 30, 2025Click on, or paste the following link into your web browser, to view the associated PDF documenthttp://www.rns-pdf.londonstockexchange.com/rns/0124G_1-2025-11-3.pdf | |||||
Notes | Sep. 30, 2025 |
| Dec. 31, 2024 | ||
|
| ||||
Assets |
| ||||
Cash and balances at the central bank | 10 | 21,886,031 |
| 136,531,020 | |
Due from banks | 11 | 227,409,917 |
| 270,829,834 | |
Loans and advances to banks, net | 13 | 26,914,884 |
| 9,555,410 | |
Loans and advances to customers, net | 14 | 455,719,759 |
| 343,542,674 | |
Derivative financial instruments | 1,222,908 |
| 819,711 | ||
Financial investments |
|
|
| ||
- Financial Assets at Fair Value through P&L | 15 | 2,203,869 |
| - | |
- Financial Assets at Fair Value through OCI | 15 | 331,039,059 |
| 234,512,167 | |
- Financial Assets at Amortized cost | 15 | 230,685,849 |
| 168,118,219 | |
Investments in associates | 16 | 44,485 |
| 98,193 | |
Other assets | 17 | 50,063,317 |
| 44,282,773 | |
Deferred tax assets | 2,855,007 |
| 2,685,331 | ||
Property and equipment | 18 | 5,533,749 | 3,997,929 | ||
Total assets |
| 1,355,578,834 |
| 1,214,973,261 | |
Liabilities and equity |
|
|
| ||
Liabilities |
|
|
| ||
Due to banks | 19 | 7,452,244 |
| 2,034,885 | |
Due to customers | 20 | 1,047,463,990 |
| 972,595,958 | |
Non-current liabilities held for sale | 1,362 |
| 1,397 | ||
Derivative financial instruments | 223,670 |
| 100,571 | ||
Current income tax liabilities | 15,857,818 |
| 18,327,968 | ||
Other liabilities | 21 | 27,009,254 |
| 21,441,169 | |
Issued debt instruments | 22 | 4,779,461 |
| 5,067,781 | |
Other loans | 30,249,278 |
| 23,962,389 | ||
Other provisions | 23 | 14,495,239 | 18,621,822 | ||
Total liabilities |
| 1,147,532,316 | 1,062,153,940 | ||
Equity |
|
|
| ||
Issued and paid capital | 30,708,510 |
| 30,431,580 | ||
Reserves | 105,653,930 |
| 63,544,579 | ||
Reserve for employee stock ownership plan (ESOP) | 2,071,247 |
| 1,868,235 | ||
Retained earnings* |
| 69,374,741 | 56,791,883 | ||
Total equity and net profit for the period / year |
| 207,808,428 | 152,636,277 | ||
Non-Controlling Interest |
| 238,090 | 183,044 | ||
Total NCI, equity and net profit for the period / year | 208,046,518 | 152,819,321 | |||
Total liabilities and equity | 1,355,578,834 | 1,214,973,261 | |||
| |||||
The accompanying notes are an integral part of these financial statements. |
| ||||
(Review report attached) |
| ||||
* | Including net profit for the period |
| |||
Condensed Consolidated Interim Income Statement for the period ended September 30, 2025 | ||||||
| Last 9 Months |
| Last 9 Months | |||
Notes |
| Sep. 30, 2025 |
| Sep. 30, 2024 | ||
|
| |||||
Interest and similar income | 158,400,209 |
| 130,999,623 | |||
Interest and similar expense |
| (79,746,672) | (65,316,717) | |||
Net interest income |
|
| 78,653,537 | 65,682,906 | ||
|
| |||||
Fee and commission income | 11,609,232 |
| 9,274,284 | |||
Fee and commission expense |
| (5,227,210) | (4,049,111) | |||
Net fee and commission income |
|
| 6,382,022 | 5,225,173 | ||
|
| |||||
Dividend income | 65,216 |
| 70,934 | |||
Net trading income | 6 | 1,282,250 |
| 18,194,491 | ||
Profits (Losses) on financial investments | 15.1 | 694,076 |
| 377,992 | ||
Administrative expenses | (12,432,780) |
| (9,180,646) | |||
Other operating income (expenses) | 7 | 668,432 |
| (17,995,808) | ||
Impairment release (charges) for credit losses | 9 |
| 7,968,084 |
| (3,745,003) | |
Bank's share in the profits / losses of associates |
| 9,787 | (8,533) | |||
Profit before income tax |
| 83,290,624 | 58,621,506 | |||
|
| |||||
Income tax expense | 29 | (21,842,182) |
| (17,207,903) | ||
Deferred tax assets (Liabilities) | 29 |
| 651,822 | 934,295 | ||
Net profit for the period |
|
| 62,100,264 | 42,347,898 | ||
|
|
| ||||
Non-Controlling Interest |
|
| 569 | (45) | ||
Bank's shareholders |
|
| 62,099,695 | 42,347,943 | ||
|
|
| ||||
Earnings per share | 8 |
|
|
| ||
Basic |
| 18.54 |
| 12.50 | ||
Diluted |
| 18.36 |
| 12.38 | ||
Condensed Consolidated Interim statement of Comprehensive Income for the period ended September 30, 2025 | ||||||
|
| Last 9 Months | Last 9 Months | |||
|
| Sep. 30, 2025 |
| Sep. 30, 2024 | ||
|
|
|
| |||
Net profit for the period |
|
| 62,100,264 |
| 42,347,898 | |
|
|
|
| |||
Transferred to RE from financial assets at fair value through OCI |
| (110,995) |
| (370,224) | ||
Net change on financial assets at fair value through comprehensive income after tax |
| 7,306,189 |
| 8,272,930 | ||
Cumulative foreign currencies translation differences |
| (274,766) |
| 883,684 | ||
Effect of ECL on debt instruments measured at fair value through OCI |
|
| (397,890) | 623,199 | ||
Total comprehensive income for the period |
|
| 68,622,802 |
| 51,757,487 | |
| ||||||
As follows: |
| |||||
Bank's shareholders |
| 68,508,336 |
| 51,757,532 | ||
Non-Controlling Interest |
|
| 114,466 | (45) | ||
Total comprehensive income for the period |
|
| 68,622,802 |
| 51,757,487 | |
Condensed Consolidated Interim Cash flows for the period ended September 30, 2025 | ||||||||||
Notes | Sep. 30, 2025 |
| Sep. 30, 2024 | |||||||
|
| |||||||||
Cash flow from operating activities |
|
| ||||||||
Profit before income tax |
| 83,290,624 |
| 58,621,506 | ||||||
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
| |||||||
Fixed assets depreciation | 18 | 1,680,325 |
| 763,079 | ||||||
Impairment release/charge for credit losses (Loans and advances to customers and banks) | 9 | (7,969,627) |
| 4,224,251 | ||||||
Net charged/released for other provisions | 23 | (4,072,083) |
| 430,005 | ||||||
Impairment release/charge for credit losses (due from banks) | 9 | 147,709 |
| 829 | ||||||
Impairment release/charge for credit losses (financial investments) | 9 | (146,166) |
| (480,077) | ||||||
Impairment release/charge for other assets | 105 |
| (11,956) | |||||||
Exchange revaluation differences for financial assets at fair value through OCI and AC | 4,669,694 |
| (18,536,183) | |||||||
Revaluation differences impairment charge for Financial Assets at Fair value through OCI | (224,869) |
| 1,193,810 | |||||||
Revaluation differences impairment charge for Financial Assets at Amortized cost | (16,709) |
| 107,207 | |||||||
Revaluation differences impairment charge for due from banks | (7,894) |
| 1,308 | |||||||
Net utilized/recovered for other provisions | 23 | (2,039) |
| (9,196) | ||||||
Exchange revaluation differences of other provisions | 23 | (52,461) |
| 3,962,591 | ||||||
Profits/losses from selling property and equipment | (8,006) |
| (2,254) | |||||||
Profits/losses from selling financial investments at fair value through OCI | 15.1 | (416,668) |
| (377,992) | ||||||
Profits/losses from selling investments in associates | 15.1 | (277,408) |
| - | ||||||
Share based payments | 990,324 |
| 804,345 | |||||||
Bank's share in the profits / losses of associates |
| (9,787) | 8,533 | |||||||
Operating profits before changes in operating assets and liabilities |
| 77,575,064 | 50,699,806 | |||||||
|
| |||||||||
Net decrease / increase in assets and liabilities |
|
|
| |||||||
Due from banks | 159,740,470 |
| (14,547,420) | |||||||
Financial assets at fair value through P&L | (2,203,869) |
| (2,066,889) | |||||||
Derivative financial instruments | (306,569) |
| (225,875) | |||||||
Loans and advances to banks and customers | (121,599,501) |
| (75,774,541) | |||||||
Other assets | (2,747,423) |
| (14,094,581) | |||||||
Due to banks | 19 | 5,417,359 |
| (8,658,023) | ||||||
Due to customers | 20 | 74,868,032 |
| 223,729,483 | ||||||
Current income tax obligations paid | (5,984,364) |
| (2,938,397) | |||||||
Non-current liabilities held for sale | (35) |
| 1,327 | |||||||
Other liabilities |
| (12,910,605) | (5,488,554) | |||||||
Net cash generated from (used in) operating activities |
| 171,848,559 |
| 150,636,336 | ||||||
|
| |||||||||
Cash flow from investing activities |
|
|
| |||||||
Proceeds from sale of investments in associates | 339,920 |
| 11,956 | |||||||
Payments for purchases of property, equipment and branches construction | (6,216,697) |
| (2,401,070) | |||||||
Proceeds from selling property and equipment | 7 | 8,006 |
| 2,254 | ||||||
Proceeds from redemption of financial assets at amortized cost | 21,382,288 |
| 1,226,638 | |||||||
Payments for purchases of financial assets at amortized cost | (84,177,641) |
| (106,105,142) | |||||||
Payments for purchases of financial assets at fair value through OCI | (191,735,116) |
| (22,138,419) | |||||||
Proceeds from selling financial assets at fair value through OCI | 98,091,318 |
| 55,475,567 | |||||||
Net cash generated from (used in) investing activities |
| (162,307,922) | (73,928,216) | |||||||
Condensed Consolidated Interim Cash flows for the period ended September 30, 2025 (Cont.) | ||||||||||
Sep. 30, 2025 |
| Sep. 30, 2024 | ||||||||
|
| |||||||||
Cash flow from financing activities |
|
|
| |||||||
Other loans | 6,286,889 |
| 7,840,786 | |||||||
Dividends | (14,773,854) |
| (5,116,159) | |||||||
Issued debt instruments | (288,320) |
| 1,738,393 | |||||||
Capital increase | 276,930 | 236,570 | ||||||||
Net cash generated from (used in) financing activities |
| (8,498,355) |
| 4,699,590 | ||||||
|
| |||||||||
Net (decrease) increase in cash and cash equivalent during the period | 1,042,282 |
| 81,407,710 | |||||||
Beginning balance of cash and cash equivalent | 226,610,721 | 234,317,913 | ||||||||
Cash and cash equivalent at the end of the period |
| 227,653,003 |
| 315,725,623 | ||||||
|
| |||||||||
Cash and cash equivalent comprise: |
|
|
| |||||||
Cash and balances at the central bank | 10 | 21,886,031 |
| 94,568,773 | ||||||
Due from banks | 227,553,557 |
| 305,240,021 | |||||||
Treasury bills and other governmental notes | 12 | 141,529,607 |
| 82,174,775 | ||||||
Obligatory reserve balance with central bank | (2,865,828) |
| (76,360,420) | |||||||
Due from banks with maturity more than three months | (19,202,757) |
| (19,125,420) | |||||||
Treasury bills and other governmental notes with maturity more than three months |
| (141,247,607) | (70,772,106) | |||||||
Total cash and cash equivalent |
| 227,653,003 |
| 315,725,623 | ||||||
Condensed Consolidated Interim statement of changes in shareholders' equity |
| ||||||||||||||||
Sep. 30, 2024 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-Controlling Interest | Total | ||
Beginning balance | 30,195,010 | 4,770,354 | 39,840,707 | 1,550,906 | - | (670,972) | 21,155 | (16,868,691) | 15,230 | 29,993,331 | 1,486,010 | 148,353 | 90,481,393 | 160,073 | 90,641,466 | ||
Capital increase | 236,570 | - | - | - | - | - | - | - | - | - | - | - | 236,570 | - | 236,570 | ||
Transferred to reserves | - | 1,438,320 | 22,582,085 | - | - | - | 1,663 | - | - | (23,398,943) | (623,125) | - | - | - | - | ||
Net profit for the period | - | - | - | - | - | - | - | - | - | 42,347,943 | - | - | 42,347,943 | (45) | 42,347,898 | ||
Dividends paid | - | - | - | - | - | - | - | - | - | (5,366,429) | - | - | (5,366,429) | (37,367) | (5,403,796) | ||
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | - | (370,224) | - | 370,224 | - | - | - | - | - | ||
Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | - | 8,272,930 | - | - | - | - | 8,272,930 | - | 8,272,930 | ||
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | - | 21,718 | (21,718) | - | - | - | - | - | ||
Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | - | 623,199 | - | - | - | - | 623,199 | - | 623,199 | ||
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | - | 804,345 | - | 804,345 | - | 804,345 | ||
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | 883,684 | 883,684 | - | 883,684 | ||
Ending balance | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (8,342,786) | 36,948 | 43,924,408 | 1,667,230 | 1,032,037 | 138,283,635 | 122,661 | 138,406,296 | ||
Sep. 30, 2025 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-Controlling Interest | Total | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
| 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (7,145,283) | 17,924 | 56,791,883 | 1,868,235 | 1,137,720 | 152,636,277 | 183,044 | 152,819,321 | ||
Capital increase | 276,930 | - | - | - | - | - | - | - | - | - | - | - | 276,930 | - | 276,930 | ||
Transferred to reserves | - | 2,771,284 | 19,758,610 | - | - | - | 2,246 | - | - | (21,744,828) | (787,312) | - | - | - | - | ||
Dividends paid | - | - | - | - | - | - | - | - | - | (14,714,434) | - | - | (14,714,434) | (59,420) | (14,773,854) | ||
Net profit for the period | - | - | - | - | - | - | - | - | - | 62,099,695 | - | - | 62,099,695 | 569 | 62,100,264 | ||
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | - | (110,995) | - | 110,995 | - | - | - | - | - | ||
Transferred from net profit to special reserve | - | - | - | - | 13,145,012 | - | - | - | - | (13,145,012) | - | - | - | - | - | ||
Transferred to general risk reserve | - | - | - | 26,186 | - | - | - | - | - | (26,186) | - | - | - | - | - | ||
Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | - | 7,192,292 | - | - | - | - | 7,192,292 | 113,897 | 7,306,189 | ||
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - | - | - | - | ||
Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | - | (397,890) | - | - | - | - | (397,890) | - | (397,890) | ||
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | - | 990,324 | - | 990,324 | - | 990,324 | ||
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | (274,766) | (274,766) | - | (274,766) | ||
Ending balance | 30,708,510 | 8,979,958 | 82,181,402 | 1,577,092 | 13,145,012 | (670,972) | 25,064 | (461,876) | 15,296 | 69,374,741 | 2,071,247 | 862,954 | 207,808,428 | 238,090 | 208,046,518 | ||
Related Shares:
Com.int.bk.regs